What is Pulsion Medical Systems SE Enterprise Value?
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Pulsion Medical Systems SE's Enterprise Value is €143.46 Mil.
Pulsion Medical Systems SE's EBIT for the trailing twelve months (TTM) ended in Dec. 2022 was €7.42 Mil. Therefore, Pulsion Medical Systems SE's EV-to-EBIT ratio for today is 19.34.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Pulsion Medical Systems SE's Enterprise Value
For the Medical Devices subindustry, Pulsion Medical Systems SE's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pulsion Medical Systems SE's Enterprise Value Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Pulsion Medical Systems SE's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Pulsion Medical Systems SE's Enterprise Value falls into.
Pulsion Medical Systems SE Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Pulsion Medical Systems SE's Enterprise Value for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pulsion Medical Systems SE (LTS:0NFX) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Pulsion Medical Systems SE's EV-to-EBIT for today is
Pulsion Medical Systems SE's current Enterprise Value is €143.46 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Pulsion Medical Systems SE's EBIT for the trailing twelve months (TTM) ended in Dec. 2022 was €7.42 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Pulsion Medical Systems SE's EV-to-EBITDA for today is:
Pulsion Medical Systems SE's current Enterprise Value is €143.46 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Pulsion Medical Systems SE's EBITDA for the trailing twelve months (TTM) ended in Dec. 2022 was €7.42 Mil.
Pulsion Medical Systems SE's current Enterprise Value is €143.46 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Pulsion Medical Systems SE's Revenue for the trailing twelve months (TTM) ended in Dec. 2022 was €29.66 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pulsion Medical Systems SE Enterprise Value Related Terms
Thank you for viewing the detailed overview of Pulsion Medical Systems SE's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Pulsion Medical Systems SE (LTS:0NFX) Business Description
Pulsion Medical Systems SE operates with its business units hemodynamic monitoring which is engaged in developing, manufacturing, and sale of systems used to monitor, diagnose, and manage physical parameters of patients in intensive care unit, and perfusion imaging which is engaged in developing, manufacturing, and sale of indocyanine green and complementary devices to visualize micro perfusion. The technology developed by the company for critical care are picco, proaqt, limon technology, and eirus technology.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LTS:0NFX has been successfully added to your 